Madrid, Spain

Victoria Moneo Ocaña

This inventor holds 1 USPTO granted patent and 4 published patent applications. Top assignee: Pharma Mar, S.a.. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Victoria Moneo Ocaña. Retrieved from https://idiyas.com/inventor/victoria-moneo-ocaña

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Victoria Moneo Ocaña: Innovator in Cancer Treatment

Introduction

Victoria Moneo Ocaña is a prominent inventor based in Madrid, Spain. She has made significant contributions to the field of oncology through her innovative research and development of cancer therapies. Her work focuses on combining various anticancer drugs to enhance treatment efficacy.

Latest Patents

Victoria holds a patent for a groundbreaking invention titled "Combination therapy with an antitumor alkaloid." This patent relates to the combination of PM01183 with several anticancer drugs, including antitumor platinum coordination complexes, antimetabolites, and various inhibitors. The invention aims to improve cancer treatment outcomes by utilizing these combinations effectively.

Career Highlights

Victoria is associated with Pharma Mar, S.A., a leading biopharmaceutical company specializing in the development of innovative therapies for cancer treatment. Her work at Pharma Mar has positioned her as a key player in the fight against cancer, contributing to the advancement of therapeutic options available to patients.

Collaborations

Victoria collaborates with esteemed colleagues such as Gema Santamaría Núñez and Luis Francisco García Fernández. These partnerships enhance her research efforts and contribute to the development of effective cancer therapies.

Conclusion

Victoria Moneo Ocaña is a trailblazer in the field of cancer treatment, with her innovative patent and collaborative efforts paving the way for advancements in oncology. Her dedication to improving patient outcomes through combination therapies is commendable and highlights the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…